Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > BLACKOUT

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Aug 03, 2021 9:15pm

50 Views

Post# 33646606

RE:RE:RE:BLACKOUT

Long term debt in Q1 2021 is much more than $5M or $10M. Have a look at note 10 in the financials. OYE what a doofus.

Newcamo wrote:
Right on! And the debt is 5 or 10M$ only... about nothing, company restructured in 2019. About no debt now.

captsecord wrote:

in fact burn rate is less than 5M$/m , the voucher cash is meaningful on a market cap of 90M$, the sp will reflect that, very easy imo 6$+ upon the voucher cash.

4Justice wrote: I heard that Thomvest and the board were under blackout because of the up comming Q2 financial statement.

When they are in blackout they can't manipulate the stock with a buy and sell strategy.

There is no interest for your $ 70 millions, because they have debt, they still have a big burn rate and the management never prouved they generate free cvsh flow without selling for cheap valuable assets they can't promote.